Clarity Pharmaceuticals (CU6.AX) Earnings Analysis
Clarity Pharmaceuticals (CU6.AX) next reports earnings on 2026-08-26, consensus EPS -0.14579 AUD. Last quarter (2026-02-25) it missed with EPS -0.153 AUD vs -0.0826 AUD est (-85.2%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E -9.14.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CU6.AX next report earnings?
| Next earnings date | 2026-08-26 |
|---|---|
| Consensus EPS estimate | -0.14579 AUD |
| Revenue estimate | 0.01B |
CU6.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | -0.153 AUD | -0.0826 AUD | -85.2% | Miss |
| 2025-02-28 | -0.07435 AUD | -0.0735 AUD | -1.2% | Miss |
| 2024-08-23 | -0.08834 AUD | -0.04 AUD | -120.8% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
CU6.AX valuation and analyst view
| Trailing P/E | -9.14 |
|---|---|
| Trailing EPS | -0.26457 AUD |
| Price / book | 4.00 |
| Dividend yield | 0.00% |
| Market cap | 0.87B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Clarity Pharmaceuticals (CU6.AX)'s next earnings date?
Clarity Pharmaceuticals is next scheduled to report on 2026-08-26, with a consensus EPS estimate of -0.14579 AUD and revenue estimate of 0.01B.
Did CU6.AX beat earnings last quarter?
In its 2026-02-25 report, CU6.AX posted EPS of -0.153 AUD versus a -0.0826 AUD estimate — a miss of 85.2%.
What is CU6.AX's earnings track record?
Over the last 3 reported quarters with consensus data, CU6.AX beat estimates 0 times (0%).
What is CU6.AX's current P/E ratio and EPS?
CU6.AX trades at a trailing P/E of -9.14 on trailing EPS of -0.2645724958491814 AUD.
What do analysts rate CU6.AX?
CU6.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.